<DOC>
	<DOCNO>NCT02478892</DOCNO>
	<brief_summary>The study prospective , observational , case-control study evaluate utility endoscopic ultrasound identification preneoplastic neoplastic pancreatic lesion patient high risk pancreatic cancer , specifically BRCA1/2 mutation .</brief_summary>
	<brief_title>Screening PDAC BRCA1/2 Patients</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>Informed consent provide Age great equal 18 Patients : Able willing attend routine followup advise BRCA2 Mutation Carriers Patients history BRCA2 Mutation , without manifestation breast ovarian cancer , age 50 . Any BRCA2 patient first degree 2 second degree family member history pancreatic cancer initiate screen 10 year prior age onset index pancreatic neoplasia . BRCA1 , ATM , &amp; PALB2 Mutation Carriers Any BRCA1 patient first degree 2 second degree family member history pancreatic cancer initiate screen 10 year prior age onset index pancreatic neoplasia . Known infection HIV , HBC , HCV Pregnancy Esophageal strictures prior treatment Zenkers Diverticulum prior treatment History abnormal post surgical ( i.e . postRouxenY Gastric Bypass ) foregut anatomy preclude endoscopic ultrasound examination pancreas .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>high risk</keyword>
	<keyword>specifically BRCA1/2 mutation</keyword>
</DOC>